Vaccination following spinal cord injury limits paralysis

Spinal cord injury results in a massive loss of neurons. It has been suggested that passive transfer of autoimmune T cells directed against myelin-associated antigens provides the spinal cord with effective neuroprotection. In August 15 Journal of Clinical Investigation, Ehud Hauben and colleagues from The Weizmann Institute of Science, Rehovot, Israel show for the first time a vaccination protocol that can be used as a strategy to prevent total paralysis after incomplete spinal cord injury.Haub

Written byTudor Toma
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Spinal cord injury results in a massive loss of neurons. It has been suggested that passive transfer of autoimmune T cells directed against myelin-associated antigens provides the spinal cord with effective neuroprotection. In August 15 Journal of Clinical Investigation, Ehud Hauben and colleagues from The Weizmann Institute of Science, Rehovot, Israel show for the first time a vaccination protocol that can be used as a strategy to prevent total paralysis after incomplete spinal cord injury.

Hauben et al. used a rat model of spinal cord injury and found that immunization with myelin basic protein (MBP) derived altered peptide ligands resulted in significant protection from neuronal loss. Vaccinated rats showed a reduced extent of paralysis, as assessed by an open-field behavioural test. Retrograde labeling of the rubrospinal tracts and magnetic resonance imaging supported the behavioural results (J Clin Invest 2001, 108:591-599).

The therapeutic window for vaccination treatment is at least one ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026, Issue 1

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Skip the Wait for Protein Stability Data with Aunty

Skip the Wait for Protein Stability Data with Aunty

Unchained Labs
Graphic of three DNA helices in various colors

An Automated DNA-to-Data Framework for Production-Scale Sequencing

illumina
Exploring Cellular Organization with Spatial Proteomics

Exploring Cellular Organization with Spatial Proteomics

Abstract illustration of spheres with multiple layers, representing endoderm, ectoderm, and mesoderm derived organoids

Organoid Origins and How to Grow Them

Thermo Fisher Logo

Products

nuclera logo

Nuclera eProtein Discovery System installed at leading Universities in Taiwan

Brandtech Logo

BRANDTECH Scientific Introduces the Transferpette® pro Micropipette: A New Twist on Comfort and Control

Biotium Logo

Biotium Launches GlycoLiner™ Cell Surface Glycoprotein Labeling Kits for Rapid and Selective Cell Surface Imaging

Colorful abstract spiral dot pattern on a black background

Thermo Scientific X and S Series General Purpose Centrifuges

Thermo Fisher Logo